Most scientists spend their graduate-school years generating reams of data that wind up in the pages of a scientific journal or collecting dust in the university library. Jose Cibelli’s PhD project wound up swatting at flies in a grassy pasture near the University of Massachusetts Amherst, where the reproductive researcher earned his degree. Shown here flanking Cibelli, Charlie and George were among the first cattle ever cloned when they were born in January 1998. These days Cibelli and his colleagues at Worcester, MA-based Cyagra are turning the once experimental technique used to produce the twin Holsteins into a commercial enterprise. In the space of a year and for a fee of $19,000, Cyagra will transform a tiny skin sample from a prized animal into a living, breathing clone of the creature. Though Cyagra-a spinoff of biotech company Advanced Cell Technology-isn’t saying publicly how many customers it’s had so far, Cibelli says it has the ability to clone an animal in a day. During a visit this summer, Technology Review senior editor Rebecca Zacks got a chance to watch Cibelli do just that, and to meet George and Charlie.
Anti-aging drugs are being tested as a way to treat covid
Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.
A quick guide to the most important AI law you’ve never heard of
The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.
It will soon be easy for self-driving cars to hide in plain sight. We shouldn’t let them.
If they ever hit our roads for real, other drivers need to know exactly what they are.
Crypto is weathering a bitter storm. Some still hold on for dear life.
When a cryptocurrency’s value is theoretical, what happens if people quit believing?
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.